Ameriprise
IDNA icon

Ameriprise’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Ameriprise’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Buy
114,331
+14,064
+14% +$408K ﹤0.01% 2698
2025
Q4 		$2.63M Buy
100,267
+28,794
+40% +$741K ﹤0.01% 2853
2025
Q3 		$1.69M Buy
71,473
+5,540
+8% +$122K ﹤0.01% 3100
2025
Q2 		$1.35M Sell
65,933
-745
-1% -$15K ﹤0.01% 3144
2025
Q1 		$1.36M Sell
66,678
-5,154
-7% -$115K ﹤0.01% 3083
2024
Q4 		$1.63M Buy
71,832
+13,721
+24% +$329K ﹤0.01% 3033
2024
Q3 		$1.43M Sell
58,111
-18,903
-25% -$461K ﹤0.01% 3066
2024
Q2 		$1.78M Sell
77,014
-3,646
-5% -$85.3K ﹤0.01% 2917
2024
Q1 		$1.94M Sell
80,660
-19,164
-19% -$449K ﹤0.01% 2886
2023
Q4 		$2.3M Buy
99,824
+1,023
+1% +$20.5K ﹤0.01% 2802
2023
Q3 		$2.01M Buy
98,801
+8,644
+10% +$194K ﹤0.01% 2813
2023
Q2 		$2.11M Buy
90,157
+15,884
+21% +$381K ﹤0.01% 2845
2023
Q1 		$1.73M Buy
74,273
+34,066
+85% +$852K ﹤0.01% 2908
2022
Q4 		$942K Buy
40,207
+1,871
+5% +$50.3K ﹤0.01% 3158
2022
Q3 		$1.01M Buy
38,336
+5,011
+15% +$155K ﹤0.01% 3107
2022
Q2 		$963K Buy
33,325
+17,310
+108% +$517K ﹤0.01% 3141
2022
Q1 		$552K Sell
16,015
-2,358
-13% -$83.3K ﹤0.01% 3447
2021
Q4 		$805K Buy
+18,373
New +$870K ﹤0.01% 3349

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Ameriprise's IDNA Position: Q1 2026 in Review

Ameriprise increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 14% in Q1 2026, buying an estimated $408K and bringing the position to 114,331 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.

Ameriprise first reported a position in IDNA in Q4 2021 and has held it in 18 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Ameriprise held 114,331 shares of iShares Genomics Immunology and Healthcare ETF worth $3.32M as of Q1 2026.
  • Ameriprise bought 14,064 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $408K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2698 holding.
  • Ameriprise first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 18 quarters since.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.